407037005: Atomoxetine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with cellular transport inhibitor mechanism of action (substance)\Noradrenaline reuptake inhibitor\Atomoxetine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Noradrenaline reuptake inhibitor\Atomoxetine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Substance with ether structure\Atomoxetine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Atomoxetine (substance)	Is a	Noradrenaline reuptake inhibitor	true	Inferred relationship	Some
Atomoxetine (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Atomoxetine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Norepinephrine reuptake inhibitor (disposition)	true	Inferred relationship	Some
Atomoxetine (substance)	Is a	éther	false	Inferred relationship	Some
Atomoxetine (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing atomoxetine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Strattera	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 18 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine (as atomoxetine hydrochloride) 25 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Strattera 10mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Strattera 18mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Strattera 25mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Strattera 40mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Strattera 60mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine hydrochloride (substance)	Is a	False	Atomoxetine (substance)	Inferred relationship	Some
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 80 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine (as atomoxetine hydrochloride) 100 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 18 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine (as atomoxetine hydrochloride) 25 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 40 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 60 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine (as atomoxetine hydrochloride) 100 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Product containing precisely atomoxetine (as atomoxetine hydrochloride) 80 milligram/1 each conventional release oral capsule (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine hydrochloride (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Atomoxetine (substance)	Inferred relationship	Some
Atomoxetine only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine (as atomoxetine hydrochloride) 4 mg/mL oral solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1
Atomoxetine (as atomoxetine hydrochloride) 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Atomoxetine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2150867015	Atomoxetine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2158664012	Atomoxetine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
52551000195119	atomoxetina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
792551000172115	atomoxétine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
66921000195114	Atomoxetin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module